Enanta Pharmaceuticals
ENTA
#8030
Rank
S$0.50 B
Marketcap
S$17.33
Share price
-1.45%
Change (1 day)
55.42%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2026 (TTM): -S$66 Million

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are S$69.21 Million. In 2025 the company made an earning of -S$81.52 Million, an increase over its 2024 earnings that were of -S$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$66 Million-19.04%
2025 -S$81.52 Million-34.07%
2024 -S$0.13 Billion-23.87%
2023 -S$0.17 Billion4.39%
2022 -S$0.16 Billion-4.4%
2021 -S$0.17 Billion91.12%
2020 -S$85.15 Million-407.13%
2019 S$27.72 M-78.63%
2018 S$0.12 B117.97%
2017 S$59.52 M-574.65%
2016 -S$12.55 Million-110.83%
2015 S$0.11 B-4.5%
2014 S$0.12 B-638.53%
2013 -S$22.53 Million-137.98%
2012 S$59.29 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.11 B-50,556.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$20.11 B-30,755.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
S$7.61 B-11,704.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$6.45 B-9,931.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$16.76 B-25,643.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.23 B-18,739.29%๐Ÿ‡บ๐Ÿ‡ธ USA